These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8905410

  • 1. EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice.
    Buchsbaum RJ, Fabry JA, Lieberman J.
    Immunol Lett; 1996 Sep; 52(2-3):145-52. PubMed ID: 8905410
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adoptive transfer of cytotoxic T lymphocytes for the treatment of transplant-associated lymphoma.
    Boyle TJ, Berend KR, DiMaio JM, Coles RE, Via DF, Lyerly HK.
    Surgery; 1993 Aug; 114(2):218-25; discussion 226. PubMed ID: 8393595
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Generation of tumor-specific T lymphocytes for the treatment of posttransplant lymphoma.
    DiMaio JM, Van Trigt P, Gaynor JW, Davis RD, Coveney E, Clary BM, Lyerly HK.
    Circulation; 1995 Nov 01; 92(9 Suppl):II202-5. PubMed ID: 7586409
    [Abstract] [Full Text] [Related]

  • 6. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.
    Khanna R, Bell S, Sherritt M, Galbraith A, Burrows SR, Rafter L, Clarke B, Slaughter R, Falk MC, Douglass J, Williams T, Elliott SL, Moss DJ.
    Proc Natl Acad Sci U S A; 1999 Aug 31; 96(18):10391-6. PubMed ID: 10468618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 31; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.
    Funakoshi S, Beckwith M, Fanslow W, Longo DL, Murphy WJ.
    Pathobiology; 1995 May 31; 63(3):133-42. PubMed ID: 8821629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
    Baiocchi RA, Caligiuri MA.
    Proc Natl Acad Sci U S A; 1994 Jun 07; 91(12):5577-81. PubMed ID: 7911241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
    Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, Klein E.
    Proc Natl Acad Sci U S A; 1986 Aug 07; 83(15):5620-4. PubMed ID: 3016710
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
    Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB.
    J Exp Med; 1991 Jan 01; 173(1):147-58. PubMed ID: 1845872
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R, Burrows SR, Nicholls J, Poulsen LM.
    Eur J Immunol; 1998 Feb 01; 28(2):451-8. PubMed ID: 9521052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.